9D9 is a commonly employed anti-CD272 antibody within immune studies , notably regarding tumor immunotherapy . Primarily, created for inhibiting CTLA-4 capability, 9D9 efficiently disrupts the inhibitory feedback cues that CTLA-4 transmits to T cells , as a result enhancing anti-cancer biological activity. Its application extends beyond fundamental